10-Q

Company

RECURSION PHARMACEUTICALS, INC.

Filed

August 8, 2024

Period of Report

June 30, 2024

Accession Number

0001601830-24-000115

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →